Senable Life Sciences Private Limited
About Senable Life Sciences Private Limited
Data last updated:
Senable Life Sciences Private Limited is a private limited company based in Jaipur, Rajasthan, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 15 May 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Jaipur, under CIN U74999RJ2017PTC058001. Its GSTIN is 08AAYCS6521M1ZH (Rajasthan).
The company has an authorised share capital of ₹2 Lakh and a paid-up capital of ₹1.92 Lakh. It is led by directors including Kshitij Kumar Saini and Namit Singh.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 212 Mahatma Gandhi Nagar Ajmar Road, Jaipur, Rajasthan, India – 302021.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.67 Cr, a growth of 19% compared to the previous year. For the same year it recorded a net loss of ₹5.78 Lakh (net margin -3.5%) and EBITDA of ₹56,340 (EBITDA margin 0.3%). Revenue has grown at a compounded annual rate (CAGR) of 8% over three years and 8% over five years.
As per MCA filings, the company has open charges of ₹40 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address212 Mahatma Gandhi Nagar Ajmar Road, Jaipur, Rajasthan, India – 302021
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Senable Life Sciences Private Limited
The main business activity of Senable Life Sciences is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Senable Life Sciences Private Limited FY 2025 filings available
Senable Life Sciences Private Limited reported revenue of ₹1.67 Cr (up 19% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Senable Life Sciences Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 8% over five years, including 19% growth in the latest year. EBITDA rose 107% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Senable Life Sciences Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹56,340 | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹5.78 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Senable Life Sciences Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.3% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -3.5% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Senable Life Sciences are in the company report.
Financial statements from FY 2018
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Senable Life Sciences Private Limited
Senable Life Sciences Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Kutis Healthcare Private Limited | ₹1.68 Cr (FY 2024) | •••• | •••• | 5.0% | •••• | Belgaum, Karnataka, India |
| Kadimi Organics Limited | ₹1.67 Cr (FY 2025) | •••• | •••• | 17981.0% | •••• | New Delhi, Delhi, India |
| Griffins Life Sciences Private Limited | ₹1.67 Cr (FY 2025) | •••• | •••• | 103.0% | •••• | Mumbai, Maharashtra, India |
| Greenage Hospitals Private Limited | ₹1.67 Cr (FY 2021) | •••• | •••• | -6.0% | •••• | Siliguri, West Bengal, India |
| Adelson Pharma Private Limited | ₹1.67 Cr (FY 2017) | •••• | •••• | •••• | Jaipur, Rajasthan, India | |
| Senable Life Sciences Private Limited this company | ₹1.67 Cr (FY 2025) | •••• | •••• | 19.0% | •••• | Jaipur, Rajasthan, India |
| Emporio Lifesciences Private Limited | ₹1.67 Cr (FY 2024) | •••• | •••• | 21.0% | •••• | Haridwar, Uttarakhand, India |
| El Shaddai Healthcare Private Limited | ₹1.66 Cr (FY 2024) | •••• | •••• | -37.0% | •••• | Chennai, Tamil Nadu, India |
| Honeybro Pharmaceutical Private Limited | ₹1.66 Cr (FY 2025) | •••• | •••• | 16.0% | •••• | Pune, Maharashtra, India |
| Ratchet Pharma Private Limited | ₹1.66 Cr (FY 2025) | •••• | •••• | 3.0% | •••• | New Delhi, Delhi, India |
| Shree Vet Enterprises Private Limited | ₹1.66 Cr (FY 2025) | •••• | •••• | -28.0% | •••• | Rajpura, Punjab, India |
Peers are the five companies nearest above and the five nearest below Senable Life Sciences by revenue in the Pharma industry (Pharma Retail and Distribution), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Senable Life Sciences Private Limited
Senable Life Sciences Private Limited is audited by GUPTA VISHAL & CO for the financial year 2020.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| GUPTA VISHAL & CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Senable Life Sciences Private Limited
Senable Life Sciences has 4 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kshitij Kumar Saini | Director | 15 May 2017 | 9 Years 4 Months | Current |
| Arihant Papdiwal | Additional Director | 13 Jul 2024 | 2 Years 2 Months | Current |
| Amit Sen | Additional Director | 13 Jul 2024 | 2 Years 2 Months | Current |
| Namit Singh | Director | 15 May 2017 | 9 Years 4 Months | Current |
Ownership and Shareholding of Senable Life Sciences Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Senable Life Sciences Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 16 Oct 2017 | Vijaya Bank | ₹40 Lakh | Open |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Senable Life Sciences Private Limited
Employment history and EPFO contributions of people linked to Senable Life Sciences.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Senable Life Sciences Private Limited
Senable Life Sciences Private Limited has 5 board changes on record since 2017: 4 appointments and 1 cessation. The latest: Amit Sen was appointed as Additional Director on 13 Jul 2024.
Credit Ratings, Litigation & Regulatory Alerts for Senable Life Sciences Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Senable Life Sciences Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Senable Life Sciences Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Senable Life Sciences Private Limited
Senable Life Sciences has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 08AAYCS6521M1ZH | Rajasthan | Active | 09 Aug 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Senable Life Sciences Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Senable Life Sciences Private Limited
Senable Life Sciences is an active private limited company based in Jaipur, Rajasthan, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 15 May 2017 (9+ years old) and is registered under CIN U74999RJ2017PTC058001.
Senable Life Sciences reported revenue of ₹1.67 Cr for FY 2025 (up 19% YoY).
Senable Life Sciences has 4 current directors:
- Kshitij Kumar Saini - Director
- Arihant Papdiwal - Additional Director
- Amit Sen - Additional Director
- Namit Singh - Director
Senable Life Sciences reported a net loss of ₹5.78 Lakh (net margin -3.5%) and EBITDA of ₹56,340 (EBITDA margin 0.3%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Senable Life Sciences is 8% over three years and 8% over five years. In the latest year (FY 2025) revenue rose 19%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Senable Life Sciences is 08AAYCS6521M1ZH, registered in Rajasthan.
The CIN (Corporate Identification Number) of Senable Life Sciences is U74999RJ2017PTC058001. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Senable Life Sciences was incorporated on 15 May 2017, making it 9+ years old. It is registered with the Registrar of Companies, Jaipur.
The peers of Senable Life Sciences by revenue are Kutis Healthcare Private Limited, Kadimi Organics Limited, Griffins Life Sciences Private Limited, Greenage Hospitals Private Limited, Adelson Pharma Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution).
Amit Sen was appointed as Additional Director on 13 Jul 2024. Arihant Papdiwal was appointed as Additional Director on 13 Jul 2024. Ajay Arora ceased to be Director on 23 Jun 2018. Senable Life Sciences has 5 board changes on record in total.
The registered office of Senable Life Sciences is at 212 Mahatma Gandhi Nagar Ajmar Road, Jaipur, Rajasthan, India – 302021.